Vildagliptin-Metformin: Is it a causative of cardiac muscle failure in Type 2 Diabetic patients?
<p>Vildagliptin is an oral anti-hyperglycaemic agent, commonly called an anti-diabetic medication that belongs to the family of medications known as Dipeptidyl Peptidase-4 (DPP-4) inhibitors. It is a medicine that is used to treat Type 2 Diabetes Mellitus [1]. </p>
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
International Journal of Clinical Endocrinology and Metabolism - Peertechz Publications,
2021-09-24.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | peertech__10_17352_ijcem_000053 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a YRKM Sai |e author |
| 245 | 0 | 0 | |a Vildagliptin-Metformin: Is it a causative of cardiac muscle failure in Type 2 Diabetic patients? |
| 260 | |b International Journal of Clinical Endocrinology and Metabolism - Peertechz Publications, |c 2021-09-24. | ||
| 520 | |a <p>Vildagliptin is an oral anti-hyperglycaemic agent, commonly called an anti-diabetic medication that belongs to the family of medications known as Dipeptidyl Peptidase-4 (DPP-4) inhibitors. It is a medicine that is used to treat Type 2 Diabetes Mellitus [1]. </p> | ||
| 540 | |a Copyright © YRKM Sai et al. | ||
| 546 | |a en | ||
| 655 | 7 | |a Perspective Study |2 local | |
| 856 | 4 | 1 | |u https://doi.org/10.17352/ijcem.000053 |z Connect to this object online. |